Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 2
1994 5
1995 1
1996 2
1997 1
1998 1
1999 5
2000 6
2001 5
2002 5
2003 2
2004 6
2005 12
2006 10
2007 16
2008 10
2009 10
2010 13
2011 5
2012 7
2013 1
2014 6
2015 5
2016 4
2017 6
2018 3
2019 5
2020 10
2021 5
2022 5
2023 2
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.
Liu E, Marin D, Banerjee P, Macapinlac HA, Thompson P, Basar R, Nassif Kerbauy L, Overman B, Thall P, Kaplan M, Nandivada V, Kaur I, Nunez Cortes A, Cao K, Daher M, Hosing C, Cohen EN, Kebriaei P, Mehta R, Neelapu S, Nieto Y, Wang M, Wierda W, Keating M, Champlin R, Shpall EJ, Rezvani K. Liu E, et al. Among authors: macapinlac ha. N Engl J Med. 2020 Feb 6;382(6):545-553. doi: 10.1056/NEJMoa1910607. N Engl J Med. 2020. PMID: 32023374 Free PMC article. Clinical Trial.
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial.
Marin D, Li Y, Basar R, Rafei H, Daher M, Dou J, Mohanty V, Dede M, Nieto Y, Uprety N, Acharya S, Liu E, Wilson J, Banerjee P, Macapinlac HA, Ganesh C, Thall PF, Bassett R, Ammari M, Rao S, Cao K, Shanley M, Kaplan M, Hosing C, Kebriaei P, Nastoupil LJ, Flowers CR, Moseley SM, Lin P, Ang S, Popat UR, Qazilbash MH, Champlin RE, Chen K, Shpall EJ, Rezvani K. Marin D, et al. Among authors: macapinlac ha. Nat Med. 2024 Mar;30(3):772-784. doi: 10.1038/s41591-023-02785-8. Epub 2024 Jan 18. Nat Med. 2024. PMID: 38238616 Free PMC article. Clinical Trial.
Spectrum of Benign Bone Conditions on NaF-PET.
Rohren EM, Macapinlac HA. Rohren EM, et al. Among authors: macapinlac ha. Semin Nucl Med. 2017 Jul;47(4):392-396. doi: 10.1053/j.semnuclmed.2017.02.008. Epub 2017 Apr 18. Semin Nucl Med. 2017. PMID: 28583278 Review.
Imatinib resistance in gastrointestinal stromal tumors.
Chen LL, Sabripour M, Andtbacka RH, Patel SR, Feig BW, Macapinlac HA, Choi H, Wu EF, Frazier ML, Benjamin RS. Chen LL, et al. Among authors: macapinlac ha. Curr Oncol Rep. 2005 Jul;7(4):293-9. doi: 10.1007/s11912-005-0053-6. Curr Oncol Rep. 2005. PMID: 15946589 Review.
18F-Fluciclovine versus PSMA PET Imaging in Primary Tumor Detection during Initial Staging of High-Risk Prostate Cancer: A Systematic Review and Meta-Analysis.
Yadav D, Hwang H, Qiao W, Upadhyay R, Chapin BF, Tang C, Aparicio A, Lopez-Olivo MA, Kang SK, Macapinlac HA, Bathala TK, Surasi DS. Yadav D, et al. Among authors: macapinlac ha. Radiol Imaging Cancer. 2022 Mar;4(2):e210091. doi: 10.1148/rycan.210091. Radiol Imaging Cancer. 2022. PMID: 35212559 Free PMC article.
169 results